Jane Street’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$372K Buy
+4,500
New +$399K ﹤0.01% 8684
2026
Q2
– Sell
-4,300
Closed -$469K – 12456
2026
Q1
$469K Buy
+4,300
New +$410K ﹤0.01% 8205
2024
Q2
– Sell
-30,000
Closed -$1.99M – 9839
2024
Q1
$1.99M Buy
+30,000
New +$1.85M ﹤0.01% 4139

Other funds holding LMAT

Jane Street's LMAT Position: Q2 2026 in Review

Jane Street sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 52,712 shares — an estimated $5.75M sold.

Jane Street first reported a position in LMAT in Q2 2018 and held it in 15 quarters. The position peaked at $5.75M in Q1 2026. 329 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Jane Street reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 52,712 LeMaitre Vascular shares in Q2 2026, an estimated $5.75M.
  • Jane Street first reported a position in LeMaitre Vascular in Q2 2018 and held it in 15 quarters.
  • Jane Street's LeMaitre Vascular position peaked at $5.75M in Q1 2026.
  • 329 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.